Shrimps Disease Diagnostic Market

Shrimps Production are increasing on the global level especially in Asia Pacific countries such as India and China. Shrimp farming is gaining popularity for production of shrimp for human consumption. Bacterial and viral infections are a major threat to the shrimp production industry in various countries. Shrimp production in many countries continues to face economic losses due to different diseases.
Shrimps Disease Diagnostic Market aims to provide a comprehensive presentation of the global market for Shrimps Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Shrimps Disease Diagnostic. Shrimps Disease Diagnostic Market contains market size and forecasts of Shrimps Disease Diagnostic in global, including the following market information:
Global Shrimps Disease Diagnostic Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Shrimps Disease Diagnostic market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Disease problems in shrimp production are poorly understood and diagnosed. Various shrimps diseases such as white spot diseases highly affect shrimp production and continue to pose a serious challenge. Diagnosis of that disease is very important. There is no therapeutic option available for viral diseases and the only option available to detect and avoid the pathogen entry into culture systems. DNA based diagnostic tool such as PCR used to test. Diagnosis tools and technologies are gaining demand for the quick and effective diagnosis of shrimp diseases for management of disease outbreaks. Assay based kits and rapid test kits are available for the shrimp's disease diagnostic market.
We surveyed the Shrimps Disease Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Shrimps Disease Diagnostic Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Shrimps Disease Diagnostic Market Segment Percentages, by Type, 2022 (%)
WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)
Global Shrimps Disease Diagnostic Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Shrimps Disease Diagnostic Market Segment Percentages, by Application, 2022 (%)
Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes
Others
Global Shrimps Disease Diagnostic Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Shrimps Disease Diagnostic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Shrimps Disease Diagnostic revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Shrimps Disease Diagnostic revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
HiMedia Laboratories
Speedy Assay Sdn Bhd
REAGEN LLC
FUJIKURA KASEI CO., LTD
GeneReach Biotechnology Corp
Thermo Fisher Scientific
Lab - Ind Resource Sdn Bhd
AquaBounty Technologies, Inc
pop bio
SUREBIO
Auro Biotechnologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Shrimps Disease Diagnostic, market overview.
Chapter 2: Global Shrimps Disease Diagnostic market size in revenue.
Chapter 3: Detailed analysis of Shrimps Disease Diagnostic company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Shrimps Disease Diagnostic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.